In Silico Drug Repurposing Approach: Investigation of <i>Mycobacterium tuberculosis</i> FadD32 Targeted by FDA-Approved Drugs

In Silico Drug Repurposing Approach: Investigation of <i>Mycobacterium tuberculosis</i> FadD32 Targeted by FDA-Approved Drugs

<b>Background</b>: Despite the enormous efforts made towards combating tuberculosis (TB), the disease remains a major global threat. Hence, new drugs with novel mechanisms against TB are urgently needed. Fatty acid degradation protein D32 (FadD32) has been identified as a promising drug...

Full description

Bibliographic Details
Main Authors: Nolwazi Thobeka Portia Ngidi, Kgothatso Eugene Machaba, Ndumiso Nhlakanipho Mhlongo
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Molecules
Subjects:
<i>Mtb</i>-FadD32
drug repurposing
MD simulations
post-MD analysis
Online Access:https://www.mdpi.com/1420-3049/27/3/668

Similar Items

Similar Items